or Try an Advanced Search...

    Holdings

    Symbol Grade Price % Change Allocation
    UL D -0.11 1.92
    NVS D 0.25 1.89
    DEO F -0.59 1.84

    Represented by ETF Holdings

    Keywords: Active Pharmaceutical Ingredients Alcohol Alcoholic Drinks Animal Health Antibiotics Beer Biotechnology Blood Test Canadian Whisky Cleaning Products Contact Lens Contact Lenses Deodorant Diagnostic Products Disposable Product Disposable Products Distilled Drinks Drink Drugs Eye
    Industries: Beverages - Wineries & Distilleries Drug Manufacturers - Major Household & Personal Products

    Recent News for First Trust International Developed Cap Strength ETF & its Holdings

    Date Stock Title
    Nov 21 DEO JOHNNIE WALKER RENEWS SUCCESSFUL LUNAR NEW YEAR PARTNERSHIP WITH VISIONARY ARTIST JAMES JEAN
    Nov 21 DEO Diageo “to pause” Crown Royal distillery construction in Canada
    Nov 20 UL Unilever ends plans to sell ice cream business to private equity - FT
    Nov 20 DEO DELEÓN Tequila Unveils Its New Campaign and Brand Platform, "Bold Spirits, Rise"
    Nov 19 DEO Diageo: No Path For Market-Beating Returns
    Nov 19 DEO Casa Redondo eyes “more muscle” with M&A on back of Safari “party drink” purchase – CEO Daniel Redondo
    Nov 19 UL Ben & Jerry’s sues parent company Unilever for stifling its stance on Gaza
    Nov 19 NVS Novartis ranks first in 2024 Access to Medicine Index
    Nov 19 NVS Novartis strengthens radiopharma leadership with Ratio Therapeutics deal
    Nov 19 NVS Astellas application rejected by FDA; Cytokinetics strikes licensing deal with Bayer
    Nov 18 NVS Novartis, Ratio to collaborate on SSTR2 radiotherapeutic for cancer
    Nov 18 NVS Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
    Nov 18 NVS Ratio Enters License and Collaboration Agreement with Novartis for SSTR2-targeting Radiotherapeutic Candidate
    Nov 18 DEO Analysis-Price hikes offer chance for Guinness rivals as Diageo pushes zero alcohol brew
    Nov 16 UL Key deals this week: Exxon, Unilever, Cardinal Health, Charter Communications and more
    Nov 15 NVS FDA reviews Sanofi and Regeneron’s Dupixent label expansion for urticaria
    Nov 15 UL Unilever scales back job cuts and shifts roles to ice cream
    Nov 15 NVS Kodiak Q3 Loss Narrower Than Expected, Pipeline Development in Focus
    Nov 15 NVS Ouch: Why a Healthcare Selloff Really Hurts in Europe
    Nov 15 UL Unilever trims European job cuts and increase staffing at Ben & Jerry's
    The investment seeks investment results that correspond generally to the price and yield of an index called The International Developed Capital Strength IndexSM. The fund seeks to achieve its investment objective by investing, under normal market conditions, at least 90% of its net assets in the common stocks and REITs that comprise the index. The index seeks to provide exposure to well-capitalized companies in the developed markets outside of the U.S. with strong market positions that have the potential to provide their stockholders with a greater degree of stability and performance over time. The fund is non-diversified.
    Exchange Traded Fund Index Fund Investment Management Real Estate Investment Trust
    Back to the Main FICS Page...